Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUDCA in Human Hypertension
NCT06025630Phase 2Recruiting
- Sponsor
- University of North Texas Health Science Center
- Start
- Aug 2023
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tauroursodeoxycholic acid in hypertension (HTN), sponsored by University of North Texas Health Science Center. Started Aug 2023; status: recruiting.
02
Drugs
tauroursodeoxycholic acid
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT06025630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06025630.